Table 2.

Comparison of the diagnostic yield of SBCE between over OGIB patients who continued and who discontinued antithrombotic agents

	Continuation group	Discontinuation group	p
Before propensity score matching
Number of patients	73	57
Diagnostic yield	36 (49.3%)	35 (61.4%)	0.169
Culprit lesion
Blood pooling only	1 (1.4%)	4 (7.0%)
Ulcer/erosion	24 (32.9%)	17 (29.8%)
Telangioectasia	7 (9.6%)	11 (19.3%)
Tumor	4 (5.5%)	3 (5.3%)
After propensity score matching
Number of patients	53	53
Diagnostic yield	26 (49.1%)	32 (60.4%)	0.242
Culprit lesion
Blood pooling only	1 (1.9%)	2 (3.8%)
Ulcer/erosion	16 (30.2%)	16 (30.2%)
Telangioectasia	5 (9.4%)	11 (20.8%)
Tumor	4 (7.5%)	3 (5.7%)

SBCE, small bowel capsule endoscopy; OGIB, obscure gastrointestinal bleeding.